Publications


2017

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS, Whalen S, et al.


Nat Genet
201704
https://pubmed.ncbi.nlm.nih.gov/28436984/

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, et al.


Oncotarget
201703
https://pubmed.ncbi.nlm.nih.gov/28179588/

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calléja FMGR, Meeks H, et al.


Cancer Res
201703
https://pubmed.ncbi.nlm.nih.gov/28283652/

Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.

Yang H, Brand JS, Fang F, Chiesa F, Johansson AL, Hall P, Czene K.


Int J Cancer
201702
https://pubmed.ncbi.nlm.nih.gov/27859142/

A clinical model for identifying the short-term risk of breast cancer.

Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P.


Breast Cancer Res
201701
https://pubmed.ncbi.nlm.nih.gov/28288659/

2016

Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry.

Wen W, Shu XO, Guo X, Cai Q, Long J, Bolla MK, Michailidou K, Dennis J, Wang Q, et al.


Breast Cancer Res
201612
https://pubmed.ncbi.nlm.nih.gov/27931260/

Differences in mammographic density between Asian and Caucasian populations: a comparative analysis.

Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan PY, Ho WK, Harun F, Rahmat K, Czene K, et al.


Breast Cancer Res Treat
201611
https://pubmed.ncbi.nlm.nih.gov/27864652/

rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk.

Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, et al.


Sci Rep
201611
https://pubmed.ncbi.nlm.nih.gov/27845421/

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients. 

Brand JS, Hedayati E, Humphreys K, Ludvigsson JF, Johansson AL, Bergh J, Hall P, Czene K.


Clin Cancer Res
201611
https://pubmed.ncbi.nlm.nih.gov/27803117/

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. 

Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, et al.


Oncotarget
201610
https://pubmed.ncbi.nlm.nih.gov/27792995/

Common diseases as determinants of menopausal age.

Li J, Eriksson M, Czene K, Hall P, Rodriguez-Wallberg KA.


Hum Reprod
201610
https://pubmed.ncbi.nlm.nih.gov/27798047/

Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.

Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, Ludvigsson JF, Czene K.


Cancer
201610
https://pubmed.ncbi.nlm.nih.gov/27727456/

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PD, et al.


Genet Med
201610
https://pubmed.ncbi.nlm.nih.gov/27711073/

Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study. 

Strand F, Humphreys K, Cheddad A, Törnberg S, Azavedo E, Shepherd J, Hall P, Czene K.


Breast Cancer Res
201610
https://pubmed.ncbi.nlm.nih.gov/27716311/

Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.

Colzani E, Clements M, Johansson AL, Liljegren A, He W, Brand J, Adolfsson J, Fornander T, Hall P, Czene K.


Br J Cancer
201610
https://pubmed.ncbi.nlm.nih.gov/27701383/

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium. 

Muranen TA, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, Greco D, Aittomäki K, et al.


Breast Cancer Res
201610
https://pubmed.ncbi.nlm.nih.gov/27716369/

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.

Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, Kaufmann S, Sivakumaran H, et al.


Am J Hum Genet
201609
https://pubmed.ncbi.nlm.nih.gov/27640304/

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.

Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Dennis J, et al.


Int J Cancer
201609
https://pubmed.ncbi.nlm.nih.gov/27087578/

Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer. 

Strand F, Humphreys K, Eriksson M, Li J, Andersson TM, Törnberg S, Azavedo E, Shepherd J, et al.


Int J Cancer
201609
https://pubmed.ncbi.nlm.nih.gov/27615710/

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

Darabi H, Beesley J, Droit A, Kar S, Nord S, Moradi Marjaneh M, Soucy P, Michailidou K, et al.


Sci Rep
201609
https://pubmed.ncbi.nlm.nih.gov/27600471/